🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05719545
Recruiting Observational

A Cohort of Patients Undergoing Percutaneous Coronary Intervention

NCT05719545 · tracked via the Priya Life Science China tracker
Sponsor
Su Guohai
Phase
Observational
Started
2021-12-01
Last updated
2023-02-09

Condition(s) studied

Acute Coronary SyndromePercutaneous Coronary InterventionMyocardial InfarctionUnstable Angina

Study summary

To investigate the risk factors involved in the occurrence and prognosis of the patients with acute coronary syndrome, patients undergoing percutaneous coronary intervention will be recruited and followed up for at least 2 years.

Eligibility

Sex
ALL
Min age
18 Years
Max age
85 Years
Healthy volunteers
No
Inclusion Criteria: * Diagnosed as acute coronary syndrome and needed to undergo percutaneous coronary intervention. * \>18 years old. Exclusion Criteria: * With malignant tumors, acute infectious diseases and advanced liver diseases. * Won't sign an inform consent.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Jinan Central Hospital Jinan Shandong Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05719545 on ClinicalTrials.gov ↗ ← All trials in China